These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 22257107)

  • 21. Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage.
    Goldstein JN; Thomas SH; Frontiero V; Joseph A; Engel C; Snider R; Smith EE; Greenberg SM; Rosand J
    Stroke; 2006 Jan; 37(1):151-5. PubMed ID: 16306465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postdischarge international normalized ratio testing and long-term clinical outcomes of patients with heart failure receiving warfarin: findings from the ADHERE registry linked to Medicare claims.
    Qualls LG; Greiner MA; Eapen ZJ; Fonarow GC; Mills RM; Klaskala W; Hernandez AF; Curtis LH
    Clin Cardiol; 2013 Dec; 36(12):757-65. PubMed ID: 24114926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulation early after mechanical valve replacement: improved management with patient self-testing.
    Thompson JL; Burkhart HM; Daly RC; Dearani JA; Joyce LD; Suri RM; Schaff HV
    J Thorac Cardiovasc Surg; 2013 Sep; 146(3):599-604. PubMed ID: 22921821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective evaluation of a method to predict fresh-frozen plasma dosage in anticoagulated patients.
    Frazee LA; Bourguet CC; Gutierrez W; Elder-Arrington J; Elackattu AE; Haller NA
    Am J Ther; 2008; 15(2):111-8. PubMed ID: 18356630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non-valvular atrial fibrillation.
    Van Den Ham HA; Klungel OH; Leufkens HG; Van Staa TP
    J Thromb Haemost; 2013 Jan; 11(1):107-15. PubMed ID: 23088617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving Anticoagulation Measurement Novel Warfarin Composite Measure.
    Razouki Z; Burgess JF; Ozonoff A; Zhao S; Berlowitz D; Rose AJ
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):600-7. PubMed ID: 26420820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of coagulopathy using prothrombin complex concentrates is associated with improved outcome compared to fresh frozen plasma in warfarin-associated intracranial hemorrhage.
    Frontera JA; Gordon E; Zach V; Jovine M; Uchino K; Hussain MS; Aledort L
    Neurocrit Care; 2014 Dec; 21(3):397-406. PubMed ID: 24671832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of the warfarin maintenance dose after completion of the 10 mg initiation nomogram: do we really need genotyping?
    Le Gal G; Carrier M; Tierney S; Majeed H; Rodger M; Wells PS
    J Thromb Haemost; 2010 Jan; 8(1):90-4. PubMed ID: 19874475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Warfarin related intracranial haemorrhage: a case-controlled study of anticoagulation monitoring prior to spontaneous subdural or intracerebral haemorrhage.
    Jeffree RL; Gordon DH; Sivasubramaniam R; Chapman A
    J Clin Neurosci; 2009 Jul; 16(7):882-5. PubMed ID: 19342242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants.
    Liew A; Eikelboom JW; O'Donnell M; Hart RG
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S34-44. PubMed ID: 23790596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The risk of hemorrhage among patients with warfarin-associated coagulopathy.
    Garcia DA; Regan S; Crowther M; Hylek EM
    J Am Coll Cardiol; 2006 Feb; 47(4):804-8. PubMed ID: 16487849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves.
    Yiu KH; Siu CW; Jim MH; Tse HF; Fan K; Chau MC; Chow WH
    Am J Cardiol; 2006 Feb; 97(3):409-11. PubMed ID: 16442406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
    Anthony CJ; Karim S; Ackroyd-Stolarz S; Fry A; Murphy NG; Christie R; Zed PJ
    Ann Pharmacother; 2011 Jul; 45(7-8):881-7. PubMed ID: 21750309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemorrhagic events lead to an increase in international normalized ratio in patients on warfarin.
    Perona S; Ford M; Rindone J
    J Pharm Pract; 2011 Oct; 24(5):494-7. PubMed ID: 22156711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.
    Meijer K; Kim YK; Carter D; Schulman S
    Thromb Haemost; 2011 Feb; 105(2):232-8. PubMed ID: 21173999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aniticoagulation in patients following prosthetic heart valve replacement.
    Akhtar RP; Abid AR; Zafar H; Khan JS
    Ann Thorac Cardiovasc Surg; 2009 Feb; 15(1):10-7. PubMed ID: 19262444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving quality measurement for anticoagulation: adding international normalized ratio variability to percent time in therapeutic range.
    Razouki Z; Ozonoff A; Zhao S; Jasuja GK; Rose AJ
    Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):664-9. PubMed ID: 25185245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Warfarin prophylaxis in patients after total knee or hip arthroplasty--international normalized ratio patterns and venous thromboembolism.
    Nordstrom BL; Kachroo S; Fraeman KH; Nutescu EA; Schein JR; Fisher A; Bookhart BK
    Curr Med Res Opin; 2011 Oct; 27(10):1973-85. PubMed ID: 21919556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subtherapeutic warfarin therapy entails an increased bleeding risk after stroke thrombolysis.
    Ruecker M; Matosevic B; Willeit P; Kirchmayr M; Zangerle A; Knoflach M; Willeit J; Kiechl S
    Neurology; 2012 Jul; 79(1):31-8. PubMed ID: 22649217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.